Real‐world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: A comparative retrospective database study

Abstract Authors: Wang L, Wei W, Miao R, Xie L, Baser O. Objectives: To compare real-world outcomes of initiating insulin glargine (GLA) vs neutral protamine Hagedorn (NPH) insulin among employees with type 2 diabetes mellitus (T2DM) who had both employer-sponsored...